CLINICAL_TRIALS
trial_result
· 2014-08-13
Clinical Trial Update: Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients [Phase 4]
Summary
Phase 4 trial evaluating early conversion from cyclosporine to everolimus in de novo kidney transplant recipients; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Renal Function | Phase 4 | Status: COMPLETED | Results posted: 2014-08-13